[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353233-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353233-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","adverse-pathological-features-and-worse-prognosis-in-rectal-cancer-compared-with-colon-cancer-in-t1-and-t2-stages","Adverse Pathological Features and Worse Prognosis in Rectal Cancer Compared With Colon Cancer in T1 and T2 Stages","","Emerging endoscopic techniques broaden minimally invasive options for early colorectal cancers, but comparative clinicopathological and outcome data for colon versus rectal cancers in Tis, T1, and T2 are limited. This retrospective single-center study analyzed pTis-T2 patients treated by endoscopic or surgical resection from 2001–2022, comparing tumor features and recurrence/metastasis by location. Rectal cancer proportions increased with invasion depth, and rectal T1/T2 showed higher lymphatic invasion, vascular invasion, and recurrence, without stage-specific metastasis differences. Results support more stringent therapy and follow-up for rectal cancers even early.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/adverse-pathological-features-and-worse-prognosis-in-rectal-cancer-compared-with-colon-cancer-in-t1-and-t2-stages/353233/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/adverse-pathological-features-and-worse-prognosis-in-rectal-cancer-compared-with-colon-cancer-in-t1-and-t2-stages/353233.png","ImageObject",300,407,{"name":42,"@type":43},"Fans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main purpose of comparing colon and rectal cancers in Tis, T1, and T2 stages?","Question",{"text":63,"@type":64},"To clarify oncologic differences by evaluating and comparing clinicopathological features and outcomes of colon versus rectal cancers in these early stages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients selected for the retrospective analysis?",{"text":68,"@type":64},"Patients with pTis, pT1, and pT2 CRCs treated at a single Japanese center between 2001 and 2022 were included if lesions were resected endoscopically or surgically; several conditions and TEM were excluded.",{"name":70,"@type":61,"acceptedAnswer":71},"What key differences were observed between rectal and colon cancers at T1 and T2 stages?",{"text":72,"@type":64},"T1 rectal cancer had higher lymphatic and vascular invasion rates and higher recurrence than T1 colon cancer, while T2 rectal cancer showed higher vascular invasion and recurrence than T2 colon cancer; lymph node and distant metastasis did not differ significantly at either stage.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353233,1790618405,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","DEN Open   \nORIGINAL ARTICLE   \nAdverse Pathological Features and Worse Prognosis in Rectal Cancer Compared With Colon Cancer in T1 and T2 Stages  \nShunto Iwasaki1  Shin-ei Kudo1  Yuta Kouyama1  Katsuro Ichimasa1  Shigenori Semba1  Yuriko Morita1  Yuki Takashina1  Tomotaka Takizawa1  Yu Nimura1  Taishi Okumura1  Kenta Nakahara1  Yasuharu Maeda1  Noriyuki Ogata1  Takemasa Hayashi1  Naruhiko Sawada1  Toshiyuki Baba1  Tetsuo Nemoto2  Masashi Misawa1  \n1 Digestive Disease Center, Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan  2 Department of Diagnostic Pathology and Laboratory  \nMedicine, Showa Medical University Northern Yokohama Hospital, Kanagawa, Japan Correspondence: Yuta Kouyama ([kouyuta1101@med.showa-u.ac.jp](kouyuta1101@med.showa-u.ac.jp))  \nReceived: 13 February 2026  Revised: 5 June 2026  Accepted: 18 June 2026  \nKeywords: rectal cancer | recurrence | T1 colorectal cancer | T2 colorectal cancer | Tis colorectal cancer  \nABSTRACT  \nBackground and Aim: Emerging endoscopic techniques are expanding opportunities for minimally invasive therapy in early colorectal cancers (CRCs). Data regarding the clinicopathological features and outcomes of colon versus rectal cancers in Tis, T1, and T2 stages remain limited. This study evaluates and compares these two entities to clarify their oncologic differences. Methods: We retrospectively analyzed patients with pTis-T2 CRCs treated by endoscopic or surgical resection at a single Japanese center between 2001 and 2022. Tumor location was classified as rectum (Ra, Rb) or colon (cecum to RS) . Clinical variables (sex and age), pathological features (tumor size, differentiation, lymphatic invasion [Ly], vascular invasion [V], and tumor budding), and recurrence and metastasis rates were compared according to tumor location.  \nResults: The proportion of rectal cancer rose with invasion depth, from 16.2%(271/1673) in Tis to 18.5%(248/1337) in T1 and 26.4%(178/675) in T2 (p \u003C 0.01) . Compared with T1 colon cancer, T1 rectal cancer showed higher rates of Ly1-2 (35.1% vs. 27.4%), V1-2 (37.9% vs. 24.6%), and recurrence (4.4% vs. 0.6%) (all p \u003C 0.05) . Similarly, T2 rectal cancer showed higher V1-2 (68.5% vs. 54.1%) and recurrence rates (13.5% vs. 5.0%) compared with colon cancer (all p \u003C 0.05) . No significant differences were observed in lymph node or distant metastasis at either T1 or T2 stages.  \nConclusions: Rectal cancers demonstrate more aggressive features and higher recurrence rates than colon cancers. Consequently, these patients require more stringent therapeutic approaches and rigorous postoperative surveillance, even in early stages.  \nTrial Registration: Umin Clinical Trials Registry, UMIN 000042622.  \n1  Introduction  \nEarly-stage colorectal cancers (CRCs) confined to the mucosa or superficial submucosa can often be removed endoscopically, preserving bowel continuity and avoiding stoma formation  \n[1–3] . Emerging techniques—such as endoscopic intermuscular dissection, transanal endoscopic myectomy (TEM), and endoscopic full-thickness resection—are expanding opportunities for minimally invasive therapy in selected T1 and T2 lesions [4–7] . These organ-preserving approaches reduce postoperative  \nYuta Kouyama and Katsuro Ichimasa contributed equally to this work.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). DEN Open published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.  \nDEN Open, 2027; 7:e70371  \n[https://doi.org/10.1002/deo2.70371](https://doi.org/10.1002/deo2.70371)  \n1 of 10  \nmorbidity and help maintain quality of life. In rectal cancer, advances in endoscopic techniques and chemoradiotherapy have enabled anus-preserving strategies even for tumors located in the Rb region [6–9] . Nevertheless, tumor location significantly shape","cbCaicWhW3I18XbF","https://ap.wps.com/l/cbCaicWhW3I18XbF","pdf",1115906,"English","# Abstract\n# Introduction\n# Methods\n## Patients and Study Design","[{\"question\":\"What was the main purpose of comparing colon and rectal cancers in Tis, T1, and T2 stages?\",\"answer\":\"To clarify oncologic differences by evaluating and comparing clinicopathological features and outcomes of colon versus rectal cancers in these early stages.\"},{\"question\":\"How were patients selected for the retrospective analysis?\",\"answer\":\"Patients with pTis, pT1, and pT2 CRCs treated at a single Japanese center between 2001 and 2022 were included if lesions were resected endoscopically or surgically; several conditions and TEM were excluded.\"},{\"question\":\"What key differences were observed between rectal and colon cancers at T1 and T2 stages?\",\"answer\":\"T1 rectal cancer had higher lymphatic and vascular invasion rates and higher recurrence than T1 colon cancer, while T2 rectal cancer showed higher vascular invasion and recurrence than T2 colon cancer; lymph node and distant metastasis did not differ significantly at either stage.\"}]","Adverse Pathological Features and Worse Prognosis in Rectal Cancer Compared With Colon Cancer in T1 and T2 Stages | PDF",1790103739,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/957541f223b86831863970c55c850a5d.webp",983,1283,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6250579f13f39d52509b6af008809c8f.webp",982,1281,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dd005344b5ed992b2bce3bae1b0ca09.webp",981,1280,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d25afefcf009ee75e2484c699a2d4c25.webp",980,1279]